Hims & Hers Appoints Tenured Pharmaceutical, Regulatory, and Quality Experts to Key Leadership Positions
Hims & Hers Appoints Tenured Pharmaceutical, Regulatory, and Quality Experts to Key Leadership Positions
Former FDA deputy commissioner and former Pfizer & Hillrom quality executive join Hims & Hers, deepening the leadership that drives the company's high standard of quality and safety
前FDA副專員和輝瑞及Hillrom的前質量執行官加入Hims&Hers,加深了推動公司高質量和安全標準的領導力
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. ("Hims & Hers") (NYSE: HIMS), the leading health and wellness platform, today announced Deb Autor, former deputy commissioner at the FDA, will join the company's board of directors, and Janet Stevens, a pharmaceutical quality expert, will join the company as Global Head of Quality & Safety. Hims & Hers continues to prioritize safety across its platform, offerings, and leadership so that every customer can have the confidence that the solutions they have access to are safe, high-quality, and personalized for their needs.
舊金山--(BUSINESS WIRE)-- Hims&Hers Health, Inc.(「Hims&Hers」)(NYSE:HIMS),領先的健康和健康平台,今日宣佈,FDA前副專員Deb Autor將加入公司的董事會,而製藥質量專家Janet Stevens將加入公司擔任全球質量和安全負責人。 Hims&Hers繼續將安全置於其平台,產品和領導層的重要位置,以便每個客戶都能確信他們可以獲得的解決方案是安全,高質量且針對其需求。
Autor brings more than 30 years of experience across pharmaceutical quality and compliance, regulatory programs, and consumer protection to Hims & Hers. She previously served as the Deputy Commissioner for Global Regulatory Operations and Policy at the FDA, where she oversaw FDA inspections, criminal investigations, and international operations for the agency. She also served as the agency's Director of the Office of Compliance for the Center for Drug Evaluation and Research, leading enforcement for drug requirements. As a trial attorney for the Department of Justice, the FDA was her primary client. She has also served as the Global Head of Regulatory Excellence at AstraZeneca and is currently the CEO of Healthcare Innovation Catalysts.
Autor在製藥質量和合規,監管計劃和消費者保護領域擁有逾30年經驗,加入Hims&Hers。她此前擔任FDA全球監管工作與政策副專員,負責監督FDA的檢查,刑事調查和國際運營。她還曾擔任FDA藥物評價與研究中心合規辦公室的負責人,領導藥品要求的執法。作爲司法部的審判律師,FDA是她的主要客戶。她還曾擔任阿斯利康全球監管卓越負責人,目前擔任醫療創新催化劑公司的CEO。
Stevens has spent her entire career in pharmaceutical quality assurance, operations, and engineering. She joins Hims & Hers from Hillrom, where she served as the Chief Quality Officer, helping the company achieve top-quartile results in global quality regulations. She also served as Pfizer's Vice President of Sterile Injectable Quality Operations, where she led the company's quality organizations and enabled successful regulatory inspections globally with regulatory authorities like the FDA, MHRA, and Health Canada.
Stevens一直致力於製藥質量保證,運營和工程方面的職業。她從Hillrom加入Hims&Hers,曾擔任首席質量官,在幫助公司達到全球質量法規的前四分之一成果方面表現優異。她還曾擔任輝瑞注射用無菌產品質量運營副總裁,領導了公司的質量組織,併成功地在全球與FDA,MHRA和加拿大衛生部等監管當局進行監管檢查。
"We've built a customer experience that prioritizes clinical excellence and the highest standard of safety and quality for every person who trusts us with their journey," said Andrew Dudum, CEO and co-founder of Hims & Hers. "The depth of expertise Deb and Janet bring to the team is incredibly valuable as we continue to scale our operations to meet the needs of the growing number of customers who come to our platform seeking healthcare solutions that fit their individual needs."
「我們建立了一個以臨床卓越和最高安全質量標準爲重點的客戶體驗,每位信任我們陪伴他們旅程的人。」 Hims & Hers的CEO兼聯合創始人Andrew Dudum表示。「Deb和Janet爲團隊帶來的專業知識深度非常寶貴,正因爲如此,我們在繼續擴大運營以滿足越來越多的客戶需求時,這份價值尤爲重要。」
"Affordable, accessible, convenient healthcare for US consumers is lacking, and Hims & Hers is addressing that need," said Deb Autor. "In my many decades in the healthcare field, this is the first company I've seen achieving scale, impact, and quality while pushing innovation in the service of patients. This is an exciting moment and I'm thrilled to be part of it."
「對於美國消費者而言,負擔得起、可獲得、便利的醫療保健服務仍然不足,而Hims & Hers正在應對這種需求。」 Deb Autor表示。「在醫療領域的幾十年間,這是我看到的第一家在服務病人方面實現規模化、影響力和質量並推動創新的公司。這是一個令人振奮的時刻,我很高興能夠成爲其中一員。」
"Customers put an immense amount of trust in healthcare companies, and Hims & Hers is one of the few companies doing the meaningful work to earn that trust," said Janet Stevens. "The safety of our operations is the foundation of connection we have with our customers. Continuing to strengthen that connection will be a critical part of impacting more lives on our platform."
「顧客對醫療公司寄予了極大的信任,而Hims & Hers是少數幾家真正通過努力贏得這種信任的公司之一。」 Janet Stevens表示。「我們運營的安全是我們與客戶之間聯繫的基礎。繼續加強這種聯繫將成爲影響更多人生命的關鍵部分。」
Autor joins health and pharmaceutical industry experts on the Hims & Hers Board of Directors including: former Novo Nordisk executive, Kåre Schultz; former CEO of the Cleveland Clinic, Dr. Toby Cosgrove; US regulatory and foreign policy expert, Anja Manuel; and former Chief Medical Officer of Walgreens and current Chief Medical Officer of Hims & Hers, Patrick Carroll, amongst others.
Autor與Hims & Hers董事會上的衛生和藥品行業專家一起加入,包括:前諾和諾德(Novo Nordisk)高管Kåre Schultz;前克利夫蘭診所(Cleveland Clinic)首席執行官Toby Cosgrove博士;美國監管和外交政策專家Anja Manuel;以及沃爾格林(Walgreens)前首席醫務官及現任Hims & Hers首席醫務官Patrick Carroll等人。
About Hims & Hers Health, Inc.
關於Hims & Hers Health公司
Hims & Hers is the leading health and wellness platform on a mission to help the world feel great through the power of better health. We believe how you feel in your body and mind transforms how you show up in life. That's why we're building a future where nothing stands in the way of harnessing this power. Hims & Hers normalizes health & wellness challenges—and innovates on their solutions—to make feeling happy and healthy easy to achieve. No two people are the same, so the company provides access to personalized care designed for results.
Hims & Hers是致力於通過更健康力量幫助世界感覺良好的領先健康和健康平台。我們相信身心狀態會改變你在生活中的表現。因此,我們正在建立一個未來,讓您能夠利用這種力量的障礙一掃而空。Hims & Hers通過標準化健康與健康挑戰,並對解決方案進行創新,使得保持快樂和健康變得易如反掌。每個人都是獨一無二的,因此公司爲實現成果設計的個性化護理得到了保障。
譯文內容由第三人軟體翻譯。